FEMY Femasys Inc.
Healthcare$0.44+29.85%ClosedMarket Cap: $12.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
4.00
P/S
5.43
EV/EBITDA
-0.83
DCF Value
$-0.52
FCF Yield
-144.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.1%
Operating Margin
-687.9%
Net Margin
-521.8%
ROE
-258.1%
ROA
-75.2%
ROIC
-118.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $424.9K | 15.5% | $-4.2M | $328.6K | $— | — |
| Q4 null | $813.4K | 115.1% | $-4.6M | $-4.0M | $— | — |
| FY null | $2.3M | 62.0% | $-17.6M | $-18.6M | $— | — |
| Q3 null | $729.4K | 30.8% | $-3.7M | $-4.2M | $— | — |
| Q2 null | $409.3K | 8.8% | $-3.9M | $-4.6M | $— | — |
| Q1 null | $341.3K | 65.6% | $-5.5M | $-5.9M | $— | — |
| Q4 null | $581.6K | 66.9% | $-4.7M | $-5.1M | $— | — |
| FY null | $1.6M | 66.6% | $-17.8M | $-18.8M | $— | — |
| Q3 null | $554.9K | 65.6% | $-5.1M | $-5.4M | $— | — |
| Q2 null | $221.5K | 67.0% | $-4.5M | $-4.7M | $— | — |
| Q1 null | $271.1K | 67.3% | $-3.5M | $-3.6M | $— | — |
| Q4 2023 | $213.1K | 63.3% | $-4.4M | $-4.4M | $-0.20 | — |